ISSN 2639-9431
Vol. 1, Issue 3, 2018September 25, 2018 EDT
Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin
Articles in Vol. 1, Issue 3, 2018
Vol. 1, Issue 3, 2018
- Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancerMattaka KhongkowTzu-Yu LiuStacey BartlettWaleed M. HusseinReshma NevagiZhongfan JiaMichael J. MonteiroJames WellsUracha Rungsardthong RuktanonchaiMariusz SkwarczynskiIstvan Toth
- Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to DoxorubicinAdam FriedmanKenny YeAlicia Rodriguez-GabinJoshua NosanchukJoel FriedmanAlan AlfieriMahantesh NavantiAngelo LandriscinaJamie RosenDavid SchairerJoy MakdisiBrandon AdlerAimee KrauszHayley McDaid
- Specific molecular recognition as a strategy to delineate tumor margin using topically applied fluorescence embedded nanoparticlesWellington PhamShawn BartonBo LiMichael SiutaVaibhav A. JanveJessica SongClinton M. HoltTakumi TomonoMasami UkawaHironori KumagaiEtsuo TobitaKevin WilsonShinji Sakuma
- Plasma samples from mouse strains and humans demonstrate different in vitro susceptibilities to complement activationBarry W NeunGábor SzénásiJános SzebeniMarina Dobrovolskaia
Friedman, Adam, Kenny Ye, Alicia Rodriguez-Gabin, Joshua Nosanchuk, Joel Friedman, Alan Alfieri, Mahantesh Navanti, et al. 2018. “Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin.” Precision Nanomedicine 1 (3): 173–82. https://doi.org/10.33218/prnano1(3).181029.1.